AAAAAA

   
Results: 1-8 |
Results: 8
Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation
Authors: Copelan, EA Bechtel, TP Avalos, BR Elder, PJ Ezzone, SA Scholl, MD Penza, SL
Citation: Ea. Copelan et al., Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation, BONE MAR TR, 27(11), 2001, pp. 1121-1124
The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy
Authors: Copelan, EA Penza, SL Theil, KS Elder, PJ Bechtel, TP Tighe, MB Ezzone, SA Scholl, MD Belt, PS Young, DC Avalos, BR
Citation: Ea. Copelan et al., The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy, BONE MAR TR, 26(10), 2000, pp. 1037-1043
Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation
Authors: Copelan, EA Penza, SL Elder, PJ Ezzone, SA Scholl, MD Bechtel, TP Belt, PS Avalos, BR
Citation: Ea. Copelan et al., Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation, BONE MAR TR, 25(12), 2000, pp. 1219-1222
Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma
Authors: Copelan, EA Penza, SL Pohlman, B Avalos, BR Goormastic, M Andresen, SW Kalaycio, M Bechtel, TP Scholl, MD Elder, PJ Ezzone, SA O'Donnell, LC Tighe, MB Risley, GL Young, DC Bolwell, BJ
Citation: Ea. Copelan et al., Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma, BONE MAR TR, 25(12), 2000, pp. 1243-1248
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors
Authors: Nash, RA Antin, JH Karanes, C Fay, JW Avalos, BR Yeager, AM Przepiorka, D Davies, S Petersen, FB Bartels, P Buell, D Fitzsimmons, W Anasetti, C Storb, R Ratanatharathorn, V
Citation: Ra. Nash et al., Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors, BLOOD, 96(6), 2000, pp. 2062-2068
Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myelogenous leukemia confer resistance to apoptosis and enhance cell survival
Authors: Hunter, MG Avalos, BR
Citation: Mg. Hunter et Br. Avalos, Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myelogenous leukemia confer resistance to apoptosis and enhance cell survival, BLOOD, 95(6), 2000, pp. 2132-2137
How many stem cells are sufficient for engraftment?
Authors: O'Donnell, LC Elder, PJ Avalos, BR
Citation: Lc. O'Donnell et al., How many stem cells are sufficient for engraftment?, CUR CLIN ON, 2000, pp. 3-27
Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia
Authors: Hunter, MG Avalos, BR
Citation: Mg. Hunter et Br. Avalos, Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia, BLOOD, 93(2), 1999, pp. 440-446
Risultati: 1-8 |